文献速递主动脉疾病

英国血管内治疗学会EXCC注册研究:GORE EXCLUDER Conformable覆膜支架联合ACTIVE CONTROL系统对主动脉瘤颈覆盖分析

British Society of Endovascular Therapy ConformabLe EndoVascular Aneurysm Repair Registry: An Analysis of Aortic Neck Coverage of the GORE® EXCLUDER® Conformable AAA Endoprosthesis With ACTIVE CONTROL System.
PubMed 文献 · J Endovasc Ther · 2025-07-18

该前瞻性多中心注册研究纳入105例肾下腹主动脉瘤患者,评估GORE EXCLUDER Conformable覆膜支架的瘤颈覆盖面积及技术临床结局。首次随访CT显示瘤颈未覆盖中位百分比为5.1%,总体技术成功率96%,1年动脉瘤相关死亡率为0%,但超说明书使用组需谨慎。

要点

  • EXCC装置在瘤颈角度达90°的适应证内患者中可精准放置,瘤颈未覆盖率低。
  • 总体技术成功率96%,超说明书组(C组)降至84.6%,需警惕。
  • 1年动脉瘤相关死亡率为0%,但4例因近端瘤颈并发症再干预,其中2例在C组。

核心结论

  • EXCC装置即使对瘤颈显著成角的患者也能准确放置,1年内临床结局可接受。
  • 对超说明书使用(C组)的患者,医生应谨慎对待。

研究设计与样本

  • 前瞻性多中心观察性队列研究,纳入2019年6月至2021年12月英国13个中心的105例年龄>55岁、非破裂肾下腹主动脉瘤需治疗患者。
  • 主要结局为首次随访CT评估的主动脉瘤颈未覆盖百分比,由核心实验室按严格方案评估。

主要发现

  • 105例患者平均年龄77.5岁,女性14/105,症状性7/105。
  • 102例有CT扫描者分组:A组(β角<60°且瘤颈>10 mm)51例,B组(β角60°-90°且瘤颈>15 mm)37例,C组(超说明书)14例。
  • 瘤颈未覆盖中位百分比总体5.1%[IQR 1.9-12.4],A组4.8%,B组6.0%,C组3.8%。
  • 总体技术成功率96%(A组97.9%,B组100%,C组84.6%)。
  • 1年总体死亡率9.1%,动脉瘤相关死亡率0%;4例因近端瘤颈并发症再干预(包括C组2/14)。

临床怎么用

  • 对于符合适应证、瘤颈成角达90°的腹主动脉瘤患者,EXCC装置可提供良好的瘤颈覆盖。
  • 超说明书使用EXCC装置时,技术成功率降低且再干预风险增加,需个体化评估并谨慎决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Primarily to evaluate the area of neck coverage and secondarily, technical and clinical outcomes of the GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC), designed to treat patients with significant angulation of the aortic neck, in routine clinical treatment of patients with abdominal aortic aneurysm (AAA). DESIGN: A prospective, multicentre, observational cohort study. MATERIALS AND METHODS: Patients aged >55 years with a nonruptured infrarenal AAA requiring treatment, were enrolled into the registry from June 2019 to December 2021. Baseline clinical, procedural, and follow-up data were collected pre-, peri-, and postoperatively at 3 and 12-months. CT images were assessed using a strict protocol at a core laboratory. The primary outcome was the estimated percentage of the total aortic neck that remained uncovered by the graft assessed on the first follow-up CT scan. RESULTS: One hundred five patients with AAA underwent endovascular aneurysm repair (EVAR) with the EXCC device in 13 UK study centers (mean age 77.5 years, 14/105 female, 7/105 symptomatic). One hundred two participants with available CT scans were placed into group A-beta angulation <60° and aortic neck >10 mm (51/102); group B-beta angulation <90° and >60° and aortic neck >15 mm (37/102); and group C-those outside of instructions for use (14/102). The primary outcome of median percentage of neck that remained uncovered after EVAR was 5.1% [IQR 1.9-12.4]; 4.8% in group A, 6.0% in group B, and 3.8% in group C. Overall technical success was 96% (97.9%, 100%, and 84.6% in group A, B, and C, respectively). One-year overall and aneurysm related mortality was 9.1% and 0%. Four patients required re-intervention for proximal neck complications (including 2/14 patients in group C). CONCLUSION: The EXCC device can be accurately placed even in patients with significant angulation of the aortic neck. Clinical outcomes are acceptable to 1 year; however, physicians should exercise caution when treating patients where the graft is placed outside the instructions for use.Clinical ImpactThis prospective registry assessed the performance of a novel device with greater conformability, and angulation control of the delivery system to treat abdominal aortic aneurysm (AAA) with up to 90° neck angulation within instructions for use (IFU). In 105 patients, the primary outcome of estimated median percentage of uncovered aortic neck was 5.1% [IQR 1.9-12.4]. In patients with anatomy conforming to IFU, there was no difference in the percentage of neck that was uncovered in angulated (>60°) versus nonangulated patients (0-60°) and no early type 1a endoleak. This suggests excellent apposition of the graft to the aortic wall despite significant angulation of the aortic neck. Clinical outcomes were acceptable to 1 year.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Ulug P, Bicknell CD, Bell R, et al. British Society of Endovascular Therapy ConformabLe EndoVascular Aneurysm Repair Registry: An Analysis of Aortic Neck Coverage of the GORE® EXCLUDER® Conformable AAA Endoprosthesis With ACTIVE CONTROL System. J Endovasc Ther. 2025. PMID: 40682292. doi:10.1177/15266028251344812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。